MYH14 Gene Deafness Autosomal Dominant Type 4 Genetic Test sale cost 4400 AED
COL4A3 Gene Alport syndrome autosomal recessive Genetic Test sale cost 4400 AED COL4A3 Gene Alport syndrome autosomal recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test sale cost 4400 AED CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MYH14 Gene Deafness Autosomal Dominant Type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYH14 gene, associated with Deafness Autosomal Dominant Type 4, plays a crucial role in the development and function of the auditory system. Mutations in this gene can lead to hearing impairment, making it a significant focus for genetic testing in individuals experiencing hearing loss with a suspected genetic basis.

The genetic test for MYH14-related deafness is a comprehensive analysis designed to detect mutations within the MYH14 gene that are known to cause Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL). This form of hearing loss is characterized by its inheritance pattern, where a single copy of the altered gene in each cell is sufficient to cause the condition, and it typically does not affect other body systems.

At DNA Labs UAE, the test for MYH14 gene-related deafness is offered at a cost of 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing technologies. This test is not only crucial for diagnosing affected individuals but also for understanding the risk of passing the condition to future generations, thereby aiding in informed family planning decisions.

Individuals who have a family history of hearing loss or have been diagnosed with hearing impairment without a known cause are potential candidates for this test. It provides a definitive diagnosis, enabling healthcare providers to offer tailored advice and management strategies for those affected by hearing loss associated with the MYH14 gene.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYH14 Gene Deafness autosomal dominant type 4 Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN26.

Test Details:

Deafness, autosomal dominant type 4 (DFNA4) is a genetic disorder characterized by progressive hearing loss. It is caused by mutations in the MYH14 gene, which encodes a protein called myosin-14. This protein is involved in the movement of cells and plays a role in the development and maintenance of the inner ear.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. It allows for the identification of specific genetic mutations or variants that may be associated with a particular disorder, such as DFNA4. NGS testing can provide valuable information about an individual’s genetic makeup and help in the diagnosis and management of genetic conditions.

If you suspect that you or someone you know may have DFNA4, a NGS genetic test can be performed to analyze the MYH14 gene for any mutations or variants that may be causing the condition. This test usually involves obtaining a blood or saliva sample from the individual, isolating the DNA, and then sequencing the MYH14 gene to identify any potential genetic changes.

It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness and availability of NGS testing for DFNA4. They can provide guidance on the testing process, interpret the results, and discuss the implications for the individual and their family members.

Test Name MYH14 Gene Deafness autosomal dominant type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN26
Test Details

Deafness, autosomal dominant type 4 (DFNA4) is a genetic disorder characterized by progressive hearing loss. It is caused by mutations in the MYH14 gene, which encodes a protein called myosin-14. This protein is involved in the movement of cells and plays a role in the development and maintenance of the inner ear.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. It allows for the identification of specific genetic mutations or variants that may be associated with a particular disorder, such as DFNA4. NGS testing can provide valuable information about an individual’s genetic makeup and help in the diagnosis and management of genetic conditions.

If you suspect that you or someone you know may have DFNA4, a NGS genetic test can be performed to analyze the MYH14 gene for any mutations or variants that may be causing the condition. This test usually involves obtaining a blood or saliva sample from the individual, isolating the DNA, and then sequencing the MYH14 gene to identify any potential genetic changes.

It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness and availability of NGS testing for DFNA4. They can provide guidance on the testing process, interpret the results, and discuss the implications for the individual and their family members.

SKU: TEST-2689 Category:

Related products